期刊文献+

国产硝呋太尔制霉素阴道软胶囊治疗阴道炎的临床研究 被引量:52

Effect of China made Nifuratel and Nysfungin Vaginal Soft Capsules on the treatment of vulvovaginal infections
下载PDF
导出
摘要 目的 评价国产硝呋太尔制霉素阴道软胶囊治疗滴虫性阴道炎、细菌性阴道病、外阴阴道念珠菌病的临床疗效和安全性。方法 随机盲法平行对照多中心临床试验,进口麦咪康帕阴道栓为对照药。结果 有效病例为滴虫性阴道炎62例、细菌性阴道病65例、外阴阴道念珠菌病65例,各适应证的试验组及对照组受试者的临床症状、体征及妇科实验检查在用药前后均有明显改善(P〈0.01),各适应证的总有效率为90.0%~96.8%,试验组与对照组的疗效相似(P〉0.05),无严重不良事件发生,对肝肾功能血尿常规等均无影响,仅个别患者有轻微的阴道局部的刺激症状。结论 临床试验结果提示,国产硝呋太尔制霉素阴道软胶囊是一种可供选择的、能用于治疗细菌性阴道病、滴虫性阴道炎及外阴阴道念珠菌病的阴道局部药物。 Objective To evaluate the effect and safety of China made Nifuratel and Nysfungin Vaginal Soft Capsules in treating trichomoniasis, bacterial vaginosis (BV) and vulvovaginal candidiasis (VVC). Methods Multicenter random control clinical trial was conducted on China made Nifuratel and Nysfungin Vaginal Soft Capsules, which was given to the women with trichomoniasis (n=62), BV (n= 65) or VVC (n= 66). Nifuratel - Nystatin Vaginal Suppositories (MACMIROR) served as control. Results The effective rates of China made Nifuratel and Nysfungin Vaginal Soft Capsules on trichomoniasis, BV and VVC were from 99. 0% to 96.8%, similar to the control groups (P〉0. 05). Only a few of them complained of irritation in vulva and vagina. Conclusions The China made Nifuratel and Nysfungin Vaginal Soft Capsules can be an option in treatment of trichomoniasis, VVC and BV.
出处 《中国妇产科临床杂志》 2007年第1期26-29,共4页 Chinese Journal of Clinical Obstetrics and Gynecology
关键词 硝呋太尔制霉素阴道软胶囊 滴虫性阴道炎 细菌性阴道病 外阴阴道念珠菌病 China made Nifuratel and Nysfungin Vaginal Soft Capules trichomoniasis bacterial vaginosis, vulvovaginal candidiasis
  • 相关文献

参考文献8

  • 1[1]Pal Z,Dosa E,Pal A.Bacterial vaginosis and other vaginal infections.Int J Gynaecol Obstet,2005,89:278-279.
  • 2[2]Ries AJ.Treatment of vaginal infections:candidiasis,bacterial vaginosis,and trichomoniasis.J Am Pharma Assoc,1997,NS37:563-569.
  • 3[3]Polatti F,Nappi RE,Brundu B,et al.Clinical study on the dose-effect relationship of a Nifuratel-Nystatin combination in the treatment of vulvovaginal infections.Arzneim Forsch Drug Res,2003,53:730-737.
  • 4沈汝棡,聂妍,何芳,刘凯波,李禾,丁辉.北京市围产期妇女生殖道感染监测与分析[J].中华围产医学杂志,2004,7(5):259-261. 被引量:12
  • 5[5]De-Seta F,Sartore A,Piccoli M.Bacterial vaginosis and preterm delivery:an open question.J Reprod Med,2005,50:313-318.
  • 6[6]El-Din SS,Reynolds MT,Ashbee HR.Investigation into the pathogenesis of vulvo-vaginal candidosis.Sex Transm Infect,2001,77:179-183.
  • 7[7]Parazzini F,Cintio E,Chianten V,et al.Determinants of different candida species infections of the genital tract in women,Sporachrom Study Group.Eur J Obstet Gynecol Reprod Biol,2002,93:141-145.
  • 8[8]Mendling W,Poli A,Magnani P.Clinical effects of nifuratel in vulvovaginal infections.A meta-analysis of metronidazole -controlled trials.Arzneim Forsch Drug Res,2002,52:725-730.

二级参考文献6

  • 1Toomey KE, Moran JS, Rafferty MP, et al. Epidemiological consideration of sexually transmitted diseases in underserved population. Infect Dis Clin North Am, 1993,7:739-752.
  • 2Younis N, Khattab H, Zurayk H, et al. A community study of gynecological and related morbidities in rural Egypt. Stud Fam Plann,1993,24:175-186.
  • 3Kaplan JE, Masur H, Holmes KK. Guidelines for preventing opportunistic infections among HIV-infected persons-2002.Recommendations of the U.S. Public Health Service and the Infectious Disease Society of America, 2002,51:1-52.
  • 4董悦.提高妊娠期性传播疾病的临床诊治水平[J].中华妇产科杂志,2001,36(8):453-455. 被引量:24
  • 5王丽珍,朱丽萍,钱尚萍,陈如钧,王哲蔚.上海市妊娠合并梅毒现况调查[J].中华围产医学杂志,2001,4(4):205-208. 被引量:58
  • 6张珠兰,王庆玲.妊娠妇女细菌性阴道病的调查[J].实用临床医学(江西),2002,3(4):119-121. 被引量:2

共引文献11

同被引文献242

引证文献52

二级引证文献328

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部